A combined intrapleural administration of dornase alfa and tissue plasminogen activator is safe in children with empyema – A pilot study

References

• Lichenstein R, Suggs AH, Campbell J. Pediatric pneumonia. Emerg Med Clin North Am. 2003;21(2):437–451.
   PubMed Web of Science ®Google Scholar
• Grijalva CG, Nuorti JP, Zhu Y, et al. Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. Clin Infect Dis. 2010;50(6):805–8813.
   PubMed Web of Science ®Google Scholar
• Wiese AD, Griffin MR, Zhu Y, et al. Changes in empyema among U.S. children in the pneumococcal conjugate vaccine era. Vaccine. 2016;34(50):6243–6249.
   PubMed Web of Science ®Google Scholar
• Balfour-Lynn IM, Abrahamson E, Cohen G, et al. BTS guidelines for the management of pleural infection in children. Thorax. 2005;60(suppl_1):i1–i21.
   PubMedGoogle Scholar
• Islam S, Calkins CM, Goldin AB, et al. The diagnosis and management of empyema in children: a comprehensive review from the APSA Outcomes and Clinical Trials Committee. J Pediatr Surg. 2012;47(11):2101–2110.
   PubMed Web of Science ®Google Scholar
• Livingston MH, Colozza S, Vogt KN, et al. Making the transition from video-assisted thoracoscopic surgery to chest tube with fibrinolytics for empyema in children: any change in outcomes? Can J Surg. 2016;59(3):167–171.
   PubMed Web of Science ®Google Scholar
• Marhuenda C, Barceló C, Fuentes I, et al. Urokinase versus VATS for treatment of empyema: a randomized multicenter clinical trial. Pediatrics. 2014;134(5):e1301–e1307.
   PubMed Web of Science ®Google Scholar
• St Peter SD, Tsao K, Spilde TL, et al. Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trial. J Pediatr Surg. 2009;44:106–111.
   PubMed Web of Science ®Google Scholar
• Sonnappa S, Cohen G, Owens CM, et al. Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med. 2006;174(2):221–227.
   PubMed Web of Science ®Google Scholar
• Gasior AC, Knott EM, Sharp SW, et al. Experience with an evidence-based protocol using fibrinolysis as first line treatment for empyema in children. J Pediatr Surg. 2013;48(6):1312–1315.
   PubMed Web of Science ®Google Scholar
• Israel EN, Blackmer AB. Tissue plasminogen activator for the treatment of parapneumonic effusions in pediatric patients. Pharmacotherapy. 2014;34(5):521–532.
   PubMed Web of Science ®Google Scholar
• Cohen E, Weinstein M, Fisman D. Cost-effectiveness of competing strategies for the treatment of pediatic empyema. Pediatrics. 2008;121(5):e1250–e1257.
   PubMed Web of Science ®Google Scholar
• Simpson G, Roomes D, Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest. 2000;117(6):1728–1733.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Hawthorne ML, Guo Y, et al. Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model. Chest. 2006;129(6):1577–1583.
   PubMed Web of Science ®Google Scholar
• Simpson G, Roomes D, Reeves B. Successful treatment of empyema thoracis with human recombinant deoxyribonuclease. Thorax. 2003;58(4):365–366.
   PubMed Web of Science ®Google Scholar
• Kacprzak G, Majewski A, Kolodziej J, et al. New therapy of pleural empyema by deoxyribonuclease. Braz J Infect Dis. 2013;17(1):90–93.
   PubMed Web of Science ®Google Scholar
• Bobek V, Majewski A, Kolostova K, et al. Intrapleural administration of Pulmozyme® alone for pleural empyema. Int J Clin Exp Med. 2015;8(11):22011–22015.
   PubMed Web of Science ®Google Scholar
• Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and Pulmozyme® in pleural infection. N Engl J Med. 2011;365(6):518–526.
   PubMed Web of Science ®Google Scholar
• Piccolo F, Pitman N, Bhatnagar R, et al. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery. Annals Am Thorac Soc. 2014;11(9):1419–1425.
   PubMedGoogle Scholar
• Livingston MH, Mahant S, Ratjen F, et al. Intrapleural dornase and tissue plasminogen activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial. Trials. 2017;18(1):293.
   PubMedGoogle Scholar